Synlett 2011(19): 2872-2874  
DOI: 10.1055/s-0031-1289863
LETTER
© Georg Thieme Verlag Stuttgart ˙ New York

Synthesis of an Advanced Intermediate toward the hNK-1 Antagonist with the Cyclopentane Core

Kenya Nakataa, Yohei Kiyotsukaa, Tomoya Kitazumeb, Yuichi Kobayashi*a
a Department of Biomolecular Engineering, Tokyo Institute of Technology, Box B52, Nagatsuta-cho 4259, Midori-ku,Yokohama 226-8501, Japan
Fax: +81(45)9245789; e-Mail: ykobayas@bio.titech.ac.jp;
b Department of Bioengineering, Tokyo Institute of Technology, Box B44, Nagatsuta-cho 4259, Midori-ku, Yokohama 226-8501, Japan
Further Information

Publication History

Received 7 September 2011
Publication Date:
09 November 2011 (online)

Abstract

Allylic substitution of monomethoxyacetate of 4-cyclopentene-1,3-diol (91% ee) with 4-FC6H4ZnBr (4 equiv) and CuCl (30 mol%) gave anti-SN2′ product, which upon epoxidation with MCPBA afforded α-epoxide stereoselectively. The epoxide was reduced with LiEt3BH, and the resulting alcohol was converted into the targeted amine by using Mitsunobu reactions twice with 3,5-(O2N)2C6H3CO2H and then with phthalimide.

    References and Notes

  • 1 Nakata K. Kiyotsuka Y. Kitazume T. Kobayashi Y. Org. Lett.  2008,  10:  1345 
  • Reviews:
  • 2a Yasuda N. Klapars A. Kohmura Y. Campos KR. Ishibashi H. Pollard D. Takezawa A. Waldman JH. Wallace DJ. Chen C.-y. Mase T. J. Synth. Org. Chem.  2011,  69:  579 
  • 2b Rameshwar P. Reddy BY. Trzaska KA. Murthy RG. Navarro P. Curr. Drug Discovery Technol.  2008,  5:  15 
  • 2c Chen L.-W. Yung KKL. Chan YS. Curr. Drug Targets  2004,  5:  197 
  • 3a

    Finke, P. E.; Meurer, L. C.; MacCoss, M.; Mills, S. G.; Sadowski, S.; Cascieri, M. A.; Metzger, J.; Eiermann, G.; MacIntyre, D. E. Abstract 98, 2000, 219th National Meeting of the ACS, San Francisco, CA, March 2000.

  • 3b

    Meurer, L. C.; Finke, P. E.; MacCoss, M.; Mills, S. G.; Sadowski, S.; Cascieri, M. A.; Metzger, J.; Eiermann, G.; MacIntyre, D. E.; Rupniak, N. M. J.; Tatersall, F. D.; Hargreaves, R. Abstract 99, 219th National Meeting of the ACS, San Francisco, CA, March 2000.

  • Related compounds with a cyclopentane ring:
  • 4a Kuethe JT. Marcoux J.-F. Wong A. Wu J. Hillier MC. Dormer PG. Davies IW. Hughes DL. J. Org. Chem.  2006,  71:  7378 
  • 4b Finke PE. Meurer LC. Levorse DA. Mills SG. MacCoss M. Sadowski S. Cascieri MA. Tsao K.-L. Chicchi GG. Metzgerd JM. MacIntyre DE. Bioorg. Med. Chem. Lett.  2006,  16:  4497 
  • 4c Campos KR. Klapars A. Kohmura Y. Pollard D. Ishibashi H. Kato S. Takezawa A. Waldman JH. Wallace DJ. Chen C.-y. Yasuda N. Org. Lett.  2011,  13:  1004 
  • 5 Meurer LC. Finke PE. Owens KA. Tsou NN. Ball RG. Mills SG. MacCoss M. Sadowski S. Cascieri MA. Tsao K.-L. Chicchi GG. Egger LA. Luell S. Metzger JM. MacIntyre DE. Rupniak NMJ. Williams AR. Hargreaves RJ. Bioorg. Med. Chem. Lett.  2006,  16:  4504 
  • 6a Kuethe JT. Wong A. Wu J. Davies IW. Dormer PG. Welch CJ. Hillier MC. Hughes DL. Reider PJ. J. Org. Chem.  2002,  67:  5993 
  • 6b Desai RC. Cicala P. Meurer LC. Finke PE. Tetrahedron Lett.  2002,  43:  4569 
  • 7 Another synthesis of 5: Menard F. Chapman TM. Dockendorff C. Lautens M. Org. Lett.  2006,  8:  4569 
  • 9a Sugai T. Mori K. Synthesis  1988,  19 
  • 9b Laumen K. Schneider MP. J. Chem. Soc., Chem. Commun.  1986,  1298 
  • 11 Igarashi J. Ishiwata H. Kobayashi Y. Tetrahedron Lett.  2004,  45:  8065 
8

Asymmetric hydrolysis of dimethyoxyacetate i (Figure 3)
at r.t. was summarized in Table 1 (see Supporting Information). Novozyme 435 afforded (1R)-4 with a sufficiently high ee, but in a low yield (supporting Information, Table 1, entry 1), whereas lipases (entries 3-5), olipase 2S (entry 6), and PLE (entry 7) were less effective than Novozyme 435.

Figure 3

10

Checked by chiral HPLC; [α]D ²4 +62 (c 0.286, CHCl3).

12

Epoxidation of ii afforded α-epoxide iii as a major product, whereas TBS ether 16 gave a 1:1 mixture of α- and β-epoxides (Scheme  [5] ).

Scheme 5

13

Mitsunobu inversion of 11 with PhCO2H afforded the benzoate. However, attempted hydrolysis gave the olefin viii as the sole product (Figure  [4] ).

Figure 4

14

Experimental procedures are presented in Supporting Information.